Examkin

Soru

Zorluk: OrtaImmunizations and Vaccine-Preventable Diseases

A primary care clinic evaluates several patients with varying medical histories. Based on current Centers for Disease Control and Prevention (CDC) guidelines, match each patient's clinical profile with the most appropriate vaccine recommendation or contraindication.

  • A 28-year-old man with HIV and a recent CD4 cell count of 120 cells/mm³Absolute contraindication to live-attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine.
  • A 32-year-old pregnant woman at 29 weeks gestation presenting for a routine prenatal visitAdministration of the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine is indicated to maximize passive neonatal immunity.
  • A 19-year-old college student newly diagnosed with a terminal complement component (C5-C9) deficiencyAdministration of both the quadrivalent meningococcal conjugate (MenACWY) and serogroup B meningococcal (MenB) vaccines is highly indicated.
  • A 45-year-old man newly diagnosed with chronic heart failure who has no adult vaccination historyAdministration of the 20-valent pneumococcal conjugate vaccine (PCV20) is indicated due to an underlying chronic medical condition.

Cevap

The HIV patient with a low CD4 count matches the absolute contraindication to live-attenuated vaccines. The pregnant woman at 29 weeks matches the Tdap indication. The patient with a terminal complement deficiency matches the indication for MenACWY and MenB vaccines. The 45-year-old with chronic heart failure matches the pneumococcal vaccine indication.
Each patient represents a unique high-risk or special population defined by the CDC for specific vaccine management. HIV with low CD4 requires avoidance of live vaccines; late second/third-trimester pregnancy requires Tdap; terminal complement deficiency demands meningococcal coverage; and chronic heart failure under age 65 necessitates pneumococcal vaccination.

Adım Adım Çözüm

1
Analyze the immune status of the 28-year-old man with HIV.
The CD4 cell count is 120 cells/mm³, which falls below the 200 cells/mm³ threshold.
Identifying severe cellular immunosuppression confirms the absolute contraindication for live-attenuated vaccines like MMR and varicella.
2
Assess the gestational timing for the 32-year-old pregnant woman.
The patient is at 29 weeks gestation, which is within the optimal 27-36 week window for vaccination.
Administering Tdap during this specific window maximizes passive immunity for the newborn against pertussis.
3
Determine the infectious risks associated with terminal complement component deficiency.
The defect isolates vulnerability specifically to encapsulated Neisseria species.
This defect creates a strict indication for both MenACWY and MenB vaccines to provide comprehensive protection against meningococcal disease.
4
Evaluate the vaccination needs of a 45-year-old with chronic heart failure.
Despite being under age 65, the diagnosis of chronic heart failure qualifies the patient for early pneumococcal vaccination.
Adults aged 19-64 with chronic heart, lung, or liver disease are at elevated risk for severe pneumococcal pneumonia and invasive disease.

Anahtar Kavram

Special population immunization guidelines dictate tailored vaccine strategies, considering immune status (e.g., CD4 count in HIV), pregnancy, specific immune pathway defects (e.g., complement deficiency), and underlying chronic organ dysfunction.
Bu soruyu puanla

Konular

Immunizations and Vaccine-Preventable Diseases

Bu konudan daha fazla soru